Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IAE0972 in Advanced Malignant Solid Tumors
NCT05396339Phase 2Unknown
- Sponsor
- SUNHO BioPharmaceutical
- Start
- Jun 2022
- Primary completion
- May 2024
- Modality
- Immunomodulatory ADCs, Fc Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of IAE0972 in advanced malignant solid tumor, sponsored by SUNHO BioPharmaceutical. Status: unknown.
02
Drugs
IAE0972
03
Conditions
advanced malignant solid tumor
Beyond the preview
Go deeper on NCT05396339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05396339.